ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,267.84
-0.74%
Dow Jones
39,065.26
-1.53%
US Dollar vs MXN
16.7216
0.34%
Brent Oil
81.305
-0.28%
Bitcoin
68,049.57
-1.52%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
23/05/202416:13Edgar (US Regulatory)Form 8-K - Current reportNYSE:RJFRaymond James Financial Inc
23/05/202416:13Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JPMJP Morgan Chase and Co
23/05/202416:12Edgar (US Regulatory)Form 11-K - Annual report of employee stock purchase, savings and similar plansNYSE:ASHAshland Inc
23/05/202416:12Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:AKTSAkoustis Technologies Inc
23/05/202416:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XELXcel Energy Inc
23/05/202416:12Business WireNimbus Therapeutics Presents New Positive Monotherapy Phase 1/2 Clinical Data of HPK1 Inhibitor in Treatment of Advanced Solid Tumors at 2024 ASCO Annual Meeting
23/05/202416:12PR Newswire (US)SILVERCORP REPORTS ADJUSTED NET INCOME OF $39.3 MILLION, $0.22 PER SHARE, AND CASH FLOW FROM OPERATIONS OF $91.6 MILLION FOR FISCAL 2024AMEX:SVMSilvercorp Metals Inc
23/05/202416:11Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
23/05/202416:11GlobeNewswire Inc.Special Olympics Florida and Orlando Health Announce Five-Year Partnership
23/05/202416:10PR Newswire (US)Facilities Management Market size is set to grow by USD 826.91 billion from 2024-2028, Increasing demand for cloud-based facilities management solutions boost the market, Technavio
23/05/202416:10Business WireBarnes & Noble Education Announces Preliminary Fiscal Year 2024 ResultsNYSE:BNEDBarnes and Noble Education Inc
23/05/202416:10Business WireBreakthrough Data on Botensilimab/Balstilimab in MSS CRC Presented at the 2024 ASCO Annual MeetingNASDAQ:AGENAgenus Inc
23/05/202416:10PR Newswire (Canada)Prix d'excellence du réseau de la santé et des services sociaux 2024 - Félicitations aux lauréates et lauréats!
23/05/202416:10PR Newswire (US)Extraordinary 80+ Acre Paradise Island, Boca Grande, FL, Hits Market After 70-Years: A Once-in-a-Lifetime Opportunity for Discerning Buyers
23/05/202416:09GlobeNewswire Inc.Ivy Brain Tumor Center announces Phase 0/2 clinical readout of niraparib indicating significant improvement in overall survival of newly diagnosed glioblastoma patients
23/05/202416:09PR Newswire (US)KinderCare Learning Companies Applauds Bipartisan Effort to Support Working Families through Child Care Access
23/05/202416:08Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ZEOWWZeo Energy Corporation
23/05/202416:08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TTMITTM Technologies Inc
23/05/202416:08Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:NCNOnCino Inc
23/05/202416:07Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:KNKnowles Corporation
23/05/202416:06GlobeNewswire Inc.G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (ASCO) MeetingNASDAQ:GTHXG1 Therapeutics Inc
23/05/202416:05Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:NCNOnCino Inc
23/05/202416:05Business WireAulos Bioscience Provides Positive Interim Phase 1/2 Data From AU-007 at 2024 ASCO Annual Meeting
23/05/202416:05GlobeNewswire Inc.Elcora Announces Share ConsolidationTSXV:ERAElcora Advanced Materials Corp
23/05/202416:05GlobeNewswire Inc.Affimed Announces Positive Early Efficacy and Progression Free Survival Results of AFM24-102 Study in EGFR Wild-Type Non-Small Cell Lung Cancer at the Annual Meeting of the American Society of Clinical Oncology 2024NASDAQ:AFMDAffimed NV
23/05/202416:05Business WireBristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research PlatformsNYSE:BMYBristol Myers Squibb Co
23/05/202416:05PR Newswire (US)EpicentRx Announces Oral Presentation for the Most Clinically Advanced TGF-β Ligand Trap, AdAPT-001, at the Upcoming 2024 ASCO Annual Meeting
23/05/202416:05PR Newswire (US)Landmark Study from Mercy BioAnalytics and University College London Demonstrates Significant Improvement Over CA125 and Ultrasound for Ovarian Cancer Screening
23/05/202416:05PR Newswire (US)IDEAYA Biosciences Announces Abstract Summary Results of ASCO 2024 Oral Presentation for Phase 2 Investigator Sponsored Study of Darovasertib in Neoadjuvant Uveal MelanomaNASDAQ:IDYAIDEAYA Biosciences Inc
23/05/202416:05PR Newswire (US)ALIMENTATION COUCHE-TARD TO RELEASE RESULTS FOR ITS FOURTH QUARTER AND FISCAL YEAR 2024 ON JUNE 25, 2024TSX:ATDAlimentation Couche Tard Inc

Su Consulta Reciente

COIN
DDXUST
DerivaDAO
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados